BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9018915)

  • 1. Poorly differentiated carcinoma of the thyroid: an aggressive type of tumour arising from thyroid follicular epithelium.
    Sakamoto A
    Curr Top Pathol; 1997; 91():45-50. PubMed ID: 9018915
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment.
    Takami H; Ozaki O; Ito K
    Arch Surg; 1996 Jun; 131(6):676. PubMed ID: 8645080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Advances in poorly differentiated thyroid carcinoma].
    Sun J; Yang D; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):850-3. PubMed ID: 22336216
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 5. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
    Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
    Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers.
    Yoo SK; Song YS; Park YJ; Seo JS
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):44-54. PubMed ID: 32207263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Fusions in Thyroid Cancer.
    Yakushina VD; Lerner LV; Lavrov AV
    Thyroid; 2018 Feb; 28(2):158-167. PubMed ID: 29281951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in differentiated thyroid gland carcinoma].
    Fonseca E; Soares P; Rossi S; Sobrinho-Simões M
    Pathologe; 1997 Jul; 18(4):275-85. PubMed ID: 9380603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial nonmedullary thyroid carcinoma.
    Malchoff CD; Malchoff DM
    Semin Surg Oncol; 1999; 16(1):16-8. PubMed ID: 9890735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid tumors with follicular architecture.
    Turk AT; Wenig BM
    Ann Diagn Pathol; 2019 Feb; 38():51-58. PubMed ID: 30419427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of YAP1 in aggressive thyroid cancer.
    Celano M; Mignogna C; Rosignolo F; Sponziello M; Iannone M; Lepore SM; Lombardo GE; Maggisano V; Verrienti A; Bulotta S; Durante C; Di Loreto C; Damante G; Russo D
    Endocrine; 2018 Jan; 59(1):209-212. PubMed ID: 28120182
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anatomo-pathology and histological prognosis of follicular thyroid carcinoma].
    de Micco C
    Ann Endocrinol (Paris); 1997; 58(3):172-82. PubMed ID: 9239238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma.
    Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL
    Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly differentiated thyroid carcinoma--it is important.
    Akslen LA; LiVolsi VA
    Am J Surg Pathol; 2000 Feb; 24(2):310-3. PubMed ID: 10680904
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of MicroRNAs in Thyroid Carcinoma.
    Zhu G; Xie L; Miller D
    Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumors of thyroid follicular epithelium: where have we been and where are we going?
    Tischler AS; DeLellis RA
    Endocr Pathol; 2002; 13(4):267-9. PubMed ID: 12665645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
    Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
    Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.